Search clinical trials for: Micro-glucagon

Total 926 results

Pierre Mégevand
Swiss National Science Foundation; Wyss Center for Bio and Neuroengineering

Recruiting

Hybrid Micro-macro Electrodes in Patients With Epilepsy (MicroEPI)

Epilepsy

Switzerland
Universitaire Ziekenhuizen KU Leuven

Recruiting

Brain Activity in Epilepsy

Epilepsy

Belgium
Dentsply Sirona Implants and Consumables

Terminated

Treatment With Fixture Microthread™ in Patients With Poor Bone Quality and no Teeth in the Upper Jaw, When Using Two-Stage Surgery

Jaw, Edentulous | Poor Bone Quality

United States, Sweden
Dentsply Sirona Implants and Consumables

Terminated

Evaluation of Treatment With Fixture Microthread™ in Patients Missing All Teeth in the Upper Jaw, When Using One-Stage Surgery

Jaw, Edentulous

United States, Germany, Spain, Sweden
Great Ormond Street Hospital for Children NHS Foundation...

Active, not recruiting

Novel Network Analysis of Intracranial Stereoelectroencephalography (NNAIS)

Epilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, Focal

United Kingdom
McGill University

Recruiting

Using Micro-filaments to Detect "Fast Ripples" and Improve the Identification of the Epileptogenic Zone (NeuroSeizure)

Epilepsy, Refractory

Canada
Zosano Pharma Corporation

Completed

Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia

Hypoglycemia

Australia
Insel Gruppe AG, University Hospital Bern

Withdrawn

Micro Glucagon During Exercise in Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

Switzerland
Steno Diabetes Center Copenhagen

Recruiting

Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes (The HYPO-AVOID)

Hypoglycemia | Type 1 Diabetes

Denmark
University Hospital, Toulouse
Dixi Medical; Centre de recherche Cerveau et Cognition (CERCO)

Not yet recruiting

Contribution of Fast-ripples to the Improvement of the Neurosurgical Management of Drug-refractory Epilepsy (NENUFAR)

Epilepsy

France
Xeris Pharmaceuticals
Empiristat, Inc.

Completed

G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus | Severe Hypoglycemia | Insulin Hypoglycemia

United States, Canada, Austria
National Nutrition and Food Technology Institute

Not yet recruiting

Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months

Pregnancy | Childhood

Iran, Islamic Republic of
Eli Lilly and Company
Locemia Solutions ULC

Completed

Evaluate the Immunogenicity of a Novel Glucagon Formulation

Diabetes Mellitus | Drug-specific Antibodies

Canada
Zealand Pharma

Completed

Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Marketed Glucagon

Hypoglycemia

Germany
Eli Lilly and Company

Completed

A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus

Hypoglycemia | Diabetes Mellitus, Type 1

Germany
Eli Lilly and Company
Jaeb Center for Health Research; Locemia Solutions ULC

Completed

Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes

Diabetes Mellitus, Type 1

United States
Sanofi

Completed

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients

Type 1 Diabetes Mellitus

United States
Eli Lilly and Company
Locemia Solutions ULC; T1D Exchange Clinic Network Coordinating Center

Completed

Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults

Diabetes Mellitus, Type 1

United States
Charite University, Berlin, Germany

Unknown

Glucagon Modulation of Ghrelin Secretion

Obesity | Diabetes Mellitus, Type 1 | Healthy Subjects

Germany
Eli Lilly and Company

Completed

A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus

Diabetes Mellitus

Japan
Zealand Pharma
SynteractHCR

Completed

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Hypoglycemia | Diabetes Mellitus, Type 1

United States, Austria, Canada, Germany
Steno Diabetes Center Copenhagen

Completed

Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

Denmark
Adocia

Completed

A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM

Type 1 Diabetes Mellitus

Germany
Xeris Pharmaceuticals
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Emissary...

Completed

PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients

Hypoglycemia

United States
Assistance Publique - Hôpitaux de Paris

Completed

In-line Filtration to Reduce Systemic Inflammatory Response Syndrome in Babies Born Very prEtErm (FRISBEE)

Babies Born Very Preterm

France
Fresenius Kabi USA, LLC

Completed

Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)

Hypoglycemia

United States
Zealand Pharma

Completed

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

Hypoglycemia | Diabetes Mellitus, Type 1

Canada, United States, Austria, Germany
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers

Hypoglycemia

United Kingdom
Sanofi

Withdrawn

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia

Type 1 Diabetes Mellitus
Université Catholique de Louvain
Fonds National de la Recherche Scientifique; BESPEED

Active, not recruiting

Phenotypic and Genotypic Characterization of New-onset Type I Diabetes (DIATAG)

Type1diabetes

Belgium
Steno Diabetes Center Copenhagen
University of Copenhagen

Completed

Hepatic Metabolic Changes in Response to Glucagon Infusion

Diabetes Mellitus | Non-Alcoholic Fatty Liver Disease | Total Pancreatectomy

Denmark
Cytrellis Biosystems, Inc.

Completed

Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity (AIS)

Wrinkle | Facial and Neck Skin Laxity

United States
ADDMEDICA SASA

Completed

Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease (PADRE)

Sickle Cell Disease

France
Legacy Health System
Juvenile Diabetes Research Foundation; Oregon Health and Science University

Completed

Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver

Type 1 Diabetes Mellitus

United States
Cytrellis Biosystems, Inc.

Completed

Efficacy of Micro-excisional Skin Removal by Micro-coring Device in Treatment of Wrinkles and Laxity of Face and Neck (MCD)

Laxity; Skin

United States
Xeris Pharmaceuticals

Completed

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Hypoglycemia | Diabetes Mellitus, Type 1

United States, Canada
Cairo University

Completed

Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema

Diabetic Retinopathy | Macula Edema

Egypt
Beijing Hospital

Completed

Radio-frequency (RF)-Based Plasma Micro-tenotomy for the Treatment of Shoulder Impingement Syndrome (RF)

Rotator Cuff Shoulder Syndrome and Allied Disorders
Zealand Pharma

Completed

ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon

Diabetes Mellitus Type 1

Germany
Case Comprehensive Cancer Center

Completed

Intra-operative Assessment of Cavernosal Nerve Stimulus Threshold

Prostatectomy

United States
Xeris Pharmaceuticals

Completed

Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D

Hypoglycemia

Canada
Novo Nordisk A/S

Completed

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Peking University Third Hospital

Not yet recruiting

A Clinical Translational Study on Repairing Articular Cartilage Injury With Autologous Adipose Gel

Articular Cartilage Defects

China
Inreda Diabetic B.V.

Withdrawn

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System (STABLE-1)

Diabetes Mellitus, Type 1

Netherlands
Al-Azhar University

Enrolling by invitation

Assessment of Maxillary Canine Retraction Using Self-ligating Brackets System Assisted With Micro-osteoperforations

Accerleration of Tooth Movement

Egypt
Milton S. Hershey Medical Center

Not yet recruiting

iLookOut Micro-learning to Improve Knowledge Retention

Attitudes | Knowledge | Practice

United States
University Hospital, Toulouse

Not yet recruiting

Study of Lymphatic Dysfunction in Primary and Secondary Lymphedema (LYMPHODYS)

Lymphedema
MedtronicNeuro

Terminated

InterStim Micro Post Market Clinical Follow-up Study (ELITE)

Overactive Bladder | Fecal Incontinence | Non-obstructive Urinary Retention

United States, Netherlands, France, Canada, Switzerland, United Kingdom
University of South Alabama

Withdrawn

Microcirculatory Assessment in Patients With Trauma and Severe Burns

Burns | Trauma

United States
Institut für Pneumologie Hagen Ambrock eV
Weinmann Geräte für Medizin GmbH + Co. KG

Completed

Arousal Analysis by Pulse Wave Amplitude in Patients With Obstructive Sleep Apnea

Obstructive Sleep Apnea

Germany

Search clinical trials for: Micro-glucagon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations